These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Testosterone replacement therapy can increase circulating endothelial progenitor cell number in men with late onset hypogonadism. Liao CH; Wu YN; Lin FY; Tsai WK; Liu SP; Chiang HS Andrology; 2013 Jul; 1(4):563-9. PubMed ID: 23653307 [TBL] [Abstract][Full Text] [Related]
23. Effects of testosterone replacement therapy on hypogonadal men with osteopenia or osteoporosis: a subanalysis of a prospective randomized controlled study in Japan (EARTH study). Shigehara K; Konaka H; Koh E; Nakashima K; Iijima M; Nohara T; Izumi K; Kitagawa Y; Kadono Y; Sugimoto K; Iwamoto T; Mizokami A; Namiki M Aging Male; 2017 Sep; 20(3):139-145. PubMed ID: 28347184 [TBL] [Abstract][Full Text] [Related]
24. Concerns about serum androgens monitoring during testosterone replacement treatments in hypogonadal male athletes: a pilot study. Di Luigi L; Sgrò P; Aversa A; Migliaccio S; Bianchini S; Botrè F; Romanelli F; Lenzi A J Sex Med; 2012 Mar; 9(3):873-86. PubMed ID: 22321254 [TBL] [Abstract][Full Text] [Related]
25. Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men. Borst SE; Yarrow JF Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1035-42. PubMed ID: 25898953 [TBL] [Abstract][Full Text] [Related]
26. Testosterone supplementation does not worsen lower urinary tract symptoms. Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078 [TBL] [Abstract][Full Text] [Related]
27. EMAS position statement: Testosterone replacement therapy in older men. Kanakis GA; Pofi R; Goulis DG; Isidori AM; Armeni E; Erel CT; Fistonić I; Hillard T; Hirschberg AL; Meczekalski B; Mendoza N; Mueck AO; Simoncini T; Stute P; van Dijken D; Rees M; Lambrinoudaki I Maturitas; 2023 Dec; 178():107854. PubMed ID: 37845136 [TBL] [Abstract][Full Text] [Related]
28. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report. Morrison BF; Reid M; Madden W; Burnett AL Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509 [TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of the 2% formulation of testosterone topical solution applied to the axillae in androgen-deficient men. Wang C; Ilani N; Arver S; McLachlan RI; Soulis T; Watkinson A Clin Endocrinol (Oxf); 2011 Dec; 75(6):836-43. PubMed ID: 21689131 [TBL] [Abstract][Full Text] [Related]
30. Symptom report and treatment experience of hypogonadal men with and without type 2 diabetes in a United States health plan. Shortridge EF; Polzer P; Donga P; Wade RL Int J Clin Pract; 2015 Jul; 69(7):783-90. PubMed ID: 25854747 [TBL] [Abstract][Full Text] [Related]
31. Improved Lower Urinary Tract Symptoms Associated With Testosterone Replacement Therapy in Japanese Men With Late-Onset Hypogonadism. Okada K; Miyake H; Ishida T; Sumii K; Enatsu N; Chiba K; Matsushita K; Fujisawa M Am J Mens Health; 2018 Sep; 12(5):1403-1408. PubMed ID: 27256990 [TBL] [Abstract][Full Text] [Related]
32. Effects of two-year testosterone replacement therapy on cognition, emotions and quality of life in young and middle-aged hypogonadal men. Lašaitė L; Čeponis J; Preikša RT; Žilaitienė B Andrologia; 2017 Apr; 49(3):. PubMed ID: 27545990 [TBL] [Abstract][Full Text] [Related]
33. A Pilot Study Using a Web Survey to Identify Characteristics That Influence Hypogonadal Men to Initiate Testosterone Replacement Therapy. Rosen RC; Seftel AD; Ruff DD; Muram D Am J Mens Health; 2018 May; 12(3):567-574. PubMed ID: 26819183 [TBL] [Abstract][Full Text] [Related]
34. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy. Sarosdy MF Cancer; 2007 Feb; 109(3):536-41. PubMed ID: 17183557 [TBL] [Abstract][Full Text] [Related]
35. Testosterone replacement therapy following radical prostatectomy. Khera M; Grober ED; Najari B; Colen JS; Mohamed O; Lamb DJ; Lipshultz LI J Sex Med; 2009 Apr; 6(4):1165-1170. PubMed ID: 19207277 [TBL] [Abstract][Full Text] [Related]
36. Obstructive Sleep Apnea Is Associated With Polycythemia in Hypogonadal Men on Testosterone Replacement Therapy. Lundy SD; Parekh NV; Shoskes DA J Sex Med; 2020 Jul; 17(7):1297-1303. PubMed ID: 32307242 [TBL] [Abstract][Full Text] [Related]
37. 12-month observation of testosterone replacement effectiveness in a general population of men. Miner MM; Bhattacharya RK; Blick G; Kushner H; Khera M Postgrad Med; 2013 Mar; 125(2):8-18. PubMed ID: 23816767 [TBL] [Abstract][Full Text] [Related]
38. Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS). Bhattacharya RK; Khera M; Blick G; Kushner H; Miner MM Clin Interv Aging; 2012; 7():321-30. PubMed ID: 22956867 [TBL] [Abstract][Full Text] [Related]
39. Symptomatic change in Japanese hypogonadal patients several years after androgen replacement therapy. Taniguchi H; Kawa G; Kinoshita H; Matsuda T Aging Male; 2011 Sep; 14(3):190-4. PubMed ID: 21557686 [TBL] [Abstract][Full Text] [Related]
40. Testosterone replacement therapy among HIV-infected men in the CFAR Network of Integrated Clinical Systems. Bhatia R; Murphy AB; Raper JL; Chamie G; Kitahata MM; Drozd DR; Mayer K; Napravnik S; Moore R; Achenbach C; AIDS; 2015 Jan; 29(1):77-81. PubMed ID: 25387318 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]